Form 4: Dyadic International CEO Receives Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Dyadic International's CEO, Mark A. Emalfarb, was granted 73,111 restricted stock units (RSUs) and 172,000 stock options on January 2, 2025.

Summary

  • Mark A. Emalfarb, CEO of Dyadic International, received 73,111 restricted stock units (RSUs) on January 2, 2025.
  • These RSUs were granted in lieu of a cash bonus for the year ended 2024 and vested immediately upon grant.
  • Mr. Emalfarb also received 172,000 stock options on the same date, with an exercise price of $1.74 per share.
  • The stock options vest in four equal installments starting on the first anniversary of the grant date and expire on January 2, 2035.
  • Following these transactions, Mr. Emalfarb beneficially owns 4,730,058 shares of Dyadic International common stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

  • The grant of RSUs and stock options aligns the CEO's interests with those of the shareholders.
  • The vesting schedule of the stock options encourages long-term performance and retention of the CEO.

Industry Context

This type of equity-based compensation is common practice for publicly traded companies to incentivize and retain key executives.

Comparison to Industry Standards

  • Equity grants are a standard component of executive compensation packages in the biotechnology industry.
  • The vesting schedule of the stock options is typical, encouraging long-term value creation.
  • The size of the grant appears to be in line with industry norms for a company of Dyadic's size and stage.

Stakeholder Impact

  • Shareholders may view the equity grants positively as they align management's interests with the company's long-term success.
  • Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
01/02/2025Date of grant for both the RSUs and stock options.
01/02/2035Expiration date of the stock options.
01/06/2025Date the form was signed by the attorney-in-fact.

Keywords

stock options, restricted stock units, RSUs, executive compensation, insider trading, beneficial ownership, Dyadic International, DYAI, Mark A. Emalfarb

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.